1st Quarter - Report

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Firm
Client
Income
—
Expenses
$679,260
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
JASON R MONEY —

Contacted: Congressional Budget Office (CBO); SENATE; White House Office; Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs S.515, S.610 and H.R.1260 - the Patent Reform Act of 2009, all provisions S.369 - Preserve Access to Affordable Generics Act, all provisions H.R.1706 - Protecting Consumers Access to Generic Drugs Act of 2009, all provisions H.R.3590 - Patient Protection and Affordable Care Act, Title VII Subtitle A - Biologics Price Competition and Innovation H.R.3962 - Affordable Health Care for America Act, Title V Subtitle C Part 2 - Biosimilars; Subtitle C Part 1 Section 2573 - Protecting Consumer Access to Generic Drugs

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
CHARLES L KINNEY —
JASON R MONEY —

Contacted: Commerce, Dept of (DOC); Federal Trade Commission (FTC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS)

Bills named: S. 369 (111th), S. 610 (111th), H.R. 1706 (111th), H.R. 3962 (111th), S. 515 (111th), H.R. 1260 (111th), H.R. 3590 (111th)

Medicare/Medicaid MMM

Medicaid Reimbursement, Medicaid Rebates, The Deficit Reduction Act of 2006, prescription drug reimbursement, Average Manufacture Price (AMP)/AMP Publication, Expanding rebates to Part D program, generic drugs H.R.3962 - Affordable Health Care for America Act - Title I, Subtitle E - Improvements to Medicare Part D; Title V Subtitle A - Drug Discount for Rural and Other Hospitals; 340B Program Integrity; Title VII Subtitle E - Financing; H.R.3590 - Patient Protection and Affordable Care Act; Title II Subtitle F - Medicaid Prescription Drug Coverage; Title VII Subtitle B - More Affordable Medicines for Children and Underserved Communities

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
CHARLES L KINNEY —
JASON R MONEY —

Contacted: Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC)

Bills named: H.R. 3590 (111th), H.R. 3962 (111th)

Budget/Appropriations BUD

Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY2011 Presidential Budget Request, FY2011 Congressional Budget and Appropriations The President's FY2011 Budget Request to Congress H.R.4872 - Reconciliation Bill, Closing the Medicare Prescription Drug "Donut Hole"

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
CHARLES L KINNEY —
JASON R MONEY —

Contacted: Office of Management & Budget (OMB); Federal Trade Commission (FTC); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); White House Office

Bills named: H.R. 4872 (111th)

Pharmacy PHA

Generic Biologics, Health Care Reform, Budget Reconciliation, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs H.R.1427 and S.726 - Promoting Innovation and Access to Life-Saving Medicines Act, all provisions H.R.1548 - Pathway for Biosimilars Act, all provisions H.R.573, all provisions S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies; Section 10609 Generic Drug Labeling H.R.3962 - Affordable Health Care for America Act, Title I Subtitle B Part 3 Section 1149A - Payment for Biosimilar Biological Products; Title V Subtitle C Part 2 - Biosimilars H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug "Donut Hole"

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
CHARLES L KINNEY —
JASON R MONEY —

Contacted: Office of Management & Budget (OMB); Federal Trade Commission (FTC); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; White House Office; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR)

Bills named: S. 501 (111th), S. 1232 (111th), H.R. 3962 (111th), H.R. 1548 (111th), H.R. 573 (111th), H.R. 1427 (111th), H.R. 3590 (111th), S. 882 (111th), S. 726 (111th), H.R. 759 (111th), H.R. 1298 (111th), S. 525 (111th), H.R. 4872 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.